entity

NURR1, PITX3, neuronal identity transcription factors

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NURR1, PITX3, neuronal identity transcription factors: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

15Connections
1Hypotheses
1Analyses
8Outgoing
7Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (19)

Knowledge base pages for this entity

PITX3 Protein

protein · 2967 words

APP Protein

protein · 2826 words

APP — Amyloid Precursor Protein

gene · 2551 words

Section 144: Advanced Myelin Repair and Oligodendrocyte Therapy in CBS/PSP

therapeutic · 1950 words

NURR1 Agonist Therapy for Parkinson's Disease

therapeutic · 1907 words

Outgoing (8)

TargetRelationTypeStr
PGC1A, SIRT1, FOXO3, mitochondrial biogenesis genesdebate_co_mentiongene0.45
RANKdebate_co_mentiongene0.45
SIRT1debate_co_mentiongene0.45
RNAdebate_co_mentiongene0.45
neurodegenerationassociated_withdisease0.40

Incoming (7)

SourceRelationTypeStr
h-9d22b570targetshypothesis0.50
Cell-type-specific essential genesdebate_co_mentiongene0.45
Disease-causing mutations with integrated reportersdebate_co_mentiongene0.45
HMGCR, LDLR, APOE regulatory regionsdebate_co_mentiongene0.45
HTT, DMPK, repeat-containing transcriptsdebate_co_mentiongene0.45

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Programmable Neuronal Circuit Repair via Epigenetic CRISPR 0.596 neurodegeneration CRISPR-based therapeutic approaches for

Mentioning Analyses (1)

Scientific analyses that reference this entity

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.757

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Canagliflozin attenuates neurodegeneration and ameliorates dyskinesia through ta [PMID:39700958] ["Abdelaziz A", "Rasheed N", "Zaki H", " International immunopharmacolo 2025 0
Canagliflozin attenuates neurodegeneration and ameliorates dyskinesia through ta [PMID:39700958] ["Abdelaziz A", "Rasheed N", "Zaki H", " International immunopharmacolo 2025 0
Nurr1 modulators - a patent review (2019-present). [PMID:40481732] ["Egner M", "Merk D"] Expert opinion on therapeutic 2025 0
Nurr1 modulators - a patent review (2019-present). [PMID:40481732] ["Egner M", "Merk D"] Expert opinion on therapeutic 2025 0
The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegenerati [PMID:37990334] ["Li T", "Tan X", "Tian L", "Jia C", "Ch Journal of neuroinflammation 2023 0
The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegenerati [PMID:37990334] ["Li T", "Tan X", "Tian L", "Jia C", "Ch Journal of neuroinflammation 2023 0
Magnetic control of tokamak plasmas through deep reinforcement learning. [PMID:35173339] Degrave J, Felici F, Buchli J, Neunert M Nature 2022 0
Delivery challenges for CRISPR therapeutics to the central nervous system [PMID:35173339] Doudna JA, Sternberg SH Nature Biotechnology 2022 0
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strate [PMID:35797147] ["Willems S", "Merk D"] Journal of medicinal chemistry 2022 0
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strate [PMID:35797147] ["Willems S", "Merk D"] Journal of medicinal chemistry 2022 0
Cardiomyocyte-derived calcitonin regulates atrial fibrosis and AF. [PMID:33199879] Fernández-Ruiz I Nature reviews. Cardiology 2021 0
SMS2 deficiency impairs PKCδ-regulated B cell tolerance in the germinal center. [PMID:34469734] Ou P, Stanek A, Huan Z, Roman CAJ, Huan Cell reports 2021 0
Immune responses to AAV-delivered CRISPR components limit therapeutic durability [PMID:34469734] Charlesworth CT, Deshpande PS, Dever DP, Nature Medicine 2021 0
Functional characterization of 84 PALB2 variants of uncertain significance. [PMID:31636395] Wiltshire T, Ducy M, Foo TK, Hu C, Lee K Genetics in medicine : officia 2020 0
Functional characterization of 84 PALB2 variants of uncertain significance. [PMID:31636395] Wiltshire T, Ducy M, Foo TK, Hu C, Lee K Genetics in medicine : officia 2020 0
CRISPR-Cas9 off-target effects in the brain: safety concerns for therapeutic gen [PMID:33199879] Trevino AE, Zhang F Nature Methods 2020 0
Pitx3 and En1 determine the size and molecular programming of the dopaminergic n [PMID:28800615] Kouwenhoven WM, von Oerthel L, Smidt MP PloS one 2017 0
Pitx3 and En1 determine the size and molecular programming of the dopaminergic n [PMID:28800615] Kouwenhoven WM, von Oerthel L, Smidt MP PloS one 2017 0
A Case-Control Study of Body Composition, Prevalence, and Curve Severity of the [PMID:29050712] Zheng Y, Dang Y, Yang Y, Sun N, Wang T, Spine deformity 2017 0
A Case-Control Study of Body Composition, Prevalence, and Curve Severity of the [PMID:29050712] Zheng Y, Dang Y, Yang Y, Sun N, Wang T, Spine deformity 2017 0

Debates (1)

Multi-agent debates referencing this entity

Evaluate the potential of CRISPR/Cas9 and related gene editing technologies for

closed · Rounds: 4 · Score: 0.95 · 2026-04-03